Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

PBEvsIBBQETF Comparison

ETF 1
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
+0.64%
VS
ETF 2
IBBQ

Invesco Nasdaq Biotechnology ETF

This fund is part of
US Health Care
+1.73%

Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. Invesco Nasdaq Biotechnology ETF (IBBQ) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Healthcare. PBE is more expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.19% for IBBQ. PBE is up 12.84% year-to-date (YTD) with +$2M in YTD flows. IBBQ performs better with 15.65% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of PBE and IBBQ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PBE vs IBBQ performance and flow charts

Performance

-2.0-1.00.01.02.03.04.0%Jun 29Jul 7Jul 14Jul 21Jul 28

Cumulative Flows

0 M1 M2 M3 M4 M5 MJun 29Jul 7Jul 14Jul 21Jul 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/28/2026
1M3MYTD1Y3Y5Y
Perf.
PBE
IBBQ
+1.97%+0.34%
+16.35%+13.13%
+12.84%+15.65%
+41.84%+47.33%
+47.30%+62.62%
+23.78%+31.41%
Flows
PBE
IBBQ
+$5M+$4M
+$6M+$3M
+$2M+$3M
-$17M+$23M
-$51M+$39M
-$45M+$3M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PBE
IBBQ
+19.07%+22.64%
+18.93%+20.25%
+20.29%+20.25%
+22.48%+21.96%
Max drawdown
PBE
IBBQ
-4.30%-5.97%
-11.70%-8.38%
-22.21%-23.78%
-34.74%-38.09%
Max drawdown duration
PBE
IBBQ
21d21d
166d48d
324d375d
1540d1543d
Trading data

Create an account to view trading data

Join for free
PBE
IBBQ
Last sale
7/28/2026 at 1:30 PM
$91.74
$32.76
Previous close
07/28/2026
$89.85
$32.42
Consolidated volume
07/28/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PBE
IBBQ
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/28/2026 at 1:30 PM
Live
Closed
PBE
IBBQ
Last price
$91.74
$32.76
1D performance
+2.10%
+1.04%
AuM$288.75 M$76.61 M
E/R0.58%0.19%
Characteristics
PBE
IBBQ
Management strategyPassivePassive
ProviderInvescoInvesco
BenchmarkDynamic Biotech & Genome Intellidex IndexNASDAQ Biotechnology Index
N° of holdings30251
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 23, 2005June 9, 2021
ESGNoNo
Advertisement
Exposure

Countries

PBE
USA
97.25%
Other
2.75%
IBBQ
USA
88.1%
Other
11.9%

Sectors

PBE
Healthcare
100%
Other
-0%
IBBQ
Healthcare
99.98%
Other
0.02%
Advertisement

Diversification

PBE

Total weight of top 15 holdings out of 15

60.29%
IBBQ

Total weight of top 15 holdings out of 15

49.38%

Top 15 holdings

Data as of June 30, 2026
PBE
Vertex Pharmaceuticals, Inc.
5.12%
Biogen, Inc.
5.08%
Amgen, Inc.
4.84%
Royalty Pharma Plc
4.74%
Regeneron Pharmaceuticals, Inc.
4.53%
Alnylam Pharmaceuticals, Inc.
4.48%
Gilead Sciences, Inc.
4.34%
United Therapeutics Corp.
4.26%
Bio-Techne Corp.
3.67%
Veracyte, Inc.
3.39%
CareDx, Inc.
3.31%
Vericel Corp.
3.27%
Repligen Corp.
3.16%
PTC Therapeutics, Inc.
3.09%
Protagonist Therapeutics, Inc.
3.02%
IBBQ
Vertex Pharmaceuticals, Inc.
8.16%
Amgen, Inc.
7.91%
Gilead Sciences, Inc.
7.07%
Regeneron Pharmaceuticals, Inc.
4.62%
Alnylam Pharmaceuticals, Inc.
2.76%
Revolution Medicines, Inc.
2.74%
Biogen, Inc.
2.26%
Illumina, Inc.
1.89%
Moderna, Inc.
1.89%
Royalty Pharma Plc
1.77%
Roivant Sciences Ltd.
1.74%
argenx SE
1.73%
United Therapeutics Corp.
1.63%
Incyte Corp.
1.61%
Insmed, Inc.
1.59%
Frequently asked questions about PBE and IBBQ

How have the PBE and IBBQ ETFs performed in 2026?

As of July 28, 2026, PBE is up 12.84% year-to-date (YTD), while IBBQ has returned 15.65%. That puts IBBQ better performer ahead so far this year.

Which ETF is attracting more investor money: PBE or IBBQ?

Year-to-date, the PBE ETF saw +$2M in flows, compared to +$3M for IBBQ.

Which ETF is more volatile: PBE or IBBQ?

Over the past year, PBE had a volatility of 18.93%, while IBBQ experienced 20.25%.

Which ETF is bigger: PBE or IBBQ?

As of July 28, 2026, PBE holds $288.75 M in assets under management (AUM), while IBBQ manages $76.61 M.

What sectors do the PBE and IBBQ ETFs invest in?

PBE leans toward sectors like Healthcare. Meanwhile, IBBQ focuses on Healthcare.

What are the top holdings of the PBE ETF and IBBQ ETF?

PBE top holdings include Vertex Pharmaceuticals, Inc., Biogen, Inc. and Amgen, Inc.. IBBQ holds in its top three: Vertex Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc..

Which ETF is more diversified: PBE or IBBQ?

PBE holds 30 securities with 60.29% of its assets in the top 15. IBBQ has 251 securities and a top 15 weight of 49.38%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder